The Information Commissioner has ruled that a major hospital failed to comply with the Data Protection Act when it provided patient details to Google’s DeepMind.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh